Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Oct;41(10):2108–2112. doi: 10.1128/aac.41.10.2108

In vivo efficacies of 5'-methylthioadenosine analogs as trypanocides.

C J Bacchi 1, K Sanabria 1, A J Spiess 1, M Vargas 1, C J Marasco Jr 1, L M Jimenez 1, B Goldberg 1, J R Sufrin 1
PMCID: PMC164078  PMID: 9333033

Abstract

5'-Deoxy-5'-(methylthio)adenosine (MTA), a key by-product of polyamine biosynthesis, is cleaved by MTA phosphorylase and is salvaged as adenine and, through conversion of the ribose moiety, methionine. An analog of MTA, 5'-deoxy-5'-(hydroxyethylthio)adenosine (HETA), is a substrate for trypanosome MTA phosphorylase and is active in vitro and in vivo against Trypanosoma brucei brucei, an agent of bovine trypanosomiasis. In this study, HETA and three O-acylated HETA derivatives were examined for their activities against model infections of T. b. brucei and Trypanosoma brucei rhodesiense, the agent of East African sleeping sickness. HETA was curative (>60%) for infections caused by 5 of 11 clinical isolates of T. b. rhodesiense when it was given to mice at 200 mg/kg of body weight for 7 days as a continuous infusion in osmotic pumps. HETA at 150 to 200 mg/kg also extended the life spans of the mice infected with four additional isolates two- to fivefold. Di- and tri-O-acetylated derivatives of HETA also proved curative for the infections, while a tri-O-propionyl derivative, although also curative, was not as effective. This study indicates that substrate analogs of MTA should be given important consideration for development as novel chemotherapies against African trypanosomiasis.

Full Text

The Full Text of this article is available as a PDF (181.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bacchi C. J., Garofalo J., Ciminelli M., Rattendi D., Goldberg B., McCann P. P., Yarlett N. Resistance to DL-alpha-difluoromethylornithine by clinical isolates of Trypanosoma brucei rhodesiense. Role of S-adenosylmethionine. Biochem Pharmacol. 1993 Aug 3;46(3):471–481. doi: 10.1016/0006-2952(93)90524-z. [DOI] [PubMed] [Google Scholar]
  2. Bacchi C. J., Nathan H. C., Livingston T., Valladares G., Saric M., Sayer P. D., Njogu A. R., Clarkson A. B., Jr Differential susceptibility to DL-alpha-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense. Antimicrob Agents Chemother. 1990 Jun;34(6):1183–1188. doi: 10.1128/aac.34.6.1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bacchi C. J., Sufrin J. R., Nathan H. C., Spiess A. J., Hannan T., Garofalo J., Alecia K., Katz L., Yarlett N. 5'-Alkyl-substituted analogs of 5'-methylthioadenosine as trypanocides. Antimicrob Agents Chemother. 1991 Jul;35(7):1315–1320. doi: 10.1128/aac.35.7.1315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Backlund P. S., Jr, Smith R. A. Methionine synthesis from 5'-methylthioadenosine in rat liver. J Biol Chem. 1981 Feb 25;256(4):1533–1535. [PubMed] [Google Scholar]
  5. Berger B. J., Carter N. S., Fairlamb A. H. Characterisation of pentamidine-resistant Trypanosoma brucei brucei. Mol Biochem Parasitol. 1995 Feb;69(2):289–298. doi: 10.1016/0166-6851(94)00215-9. [DOI] [PubMed] [Google Scholar]
  6. Byers T. L., Bush T. L., McCann P. P., Bitonti A. J. Antitrypanosomal effects of polyamine biosynthesis inhibitors correlate with increases in Trypanosoma brucei brucei S-adenosyl-L-methionine. Biochem J. 1991 Mar 1;274(Pt 2):527–533. doi: 10.1042/bj2740527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carter N. S., Berger B. J., Fairlamb A. H. Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei. J Biol Chem. 1995 Nov 24;270(47):28153–28157. doi: 10.1074/jbc.270.47.28153. [DOI] [PubMed] [Google Scholar]
  8. Carter N. S., Fairlamb A. H. Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature. 1993 Jan 14;361(6408):173–176. doi: 10.1038/361173a0. [DOI] [PubMed] [Google Scholar]
  9. Goldberg B., Rattendi D., Yarlett N., Lloyd D., Bacchi C. J. Effects of carboxylmethylation and polyamine synthesis inhibitors on methylation of Trypanosoma brucei cellular proteins and lipids. J Eukaryot Microbiol. 1997 Jul-Aug;44(4):352–358. doi: 10.1111/j.1550-7408.1997.tb05677.x. [DOI] [PubMed] [Google Scholar]
  10. Goldberg B., Yarlett N., Rattendi D., Lloyd D., Bacchi C. J. Rapid methylation of cell proteins and lipids in Trypanosoma brucei. J Eukaryot Microbiol. 1997 Jul-Aug;44(4):345–351. doi: 10.1111/j.1550-7408.1997.tb05676.x. [DOI] [PubMed] [Google Scholar]
  11. Goldberg B., Yarlett N., Sufrin J., Lloyd D., Bacchi C. J. A unique transporter of S-adenosylmethionine in African trypanosomes. FASEB J. 1997 Mar;11(4):256–260. doi: 10.1096/fasebj.11.4.9068614. [DOI] [PubMed] [Google Scholar]
  12. Kuzoe F. A. Current situation of African trypanosomiasis. Acta Trop. 1993 Sep;54(3-4):153–162. doi: 10.1016/0001-706x(93)90089-t. [DOI] [PubMed] [Google Scholar]
  13. Marton L. J., Pegg A. E. Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol. 1995;35:55–91. doi: 10.1146/annurev.pa.35.040195.000415. [DOI] [PubMed] [Google Scholar]
  14. Pegg A. E. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res. 1988 Feb 15;48(4):759–774. [PubMed] [Google Scholar]
  15. Sufrin J. R., Rattendi D., Spiess A. J., Lane S., Marasco C. J., Jr, Bacchi C. J. Antitrypanosomal activity of purine nucleosides can be enhanced by their conversion to O-acetylated derivatives. Antimicrob Agents Chemother. 1996 Nov;40(11):2567–2572. doi: 10.1128/aac.40.11.2567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sufrin J. R., Spiess A. J., Kramer D. L., Libby P. R., Miller J. T., Bernacki R. J., Lee Y. H., Borchardt R. T., Porter C. W. Targeting 5'-deoxy-5'-(methylthio)adenosine phosphorylase by 5'-haloalkyl analogues of 5'-deoxy-5'-(methylthio)adenosine. J Med Chem. 1991 Aug;34(8):2600–2606. doi: 10.1021/jm00112a039. [DOI] [PubMed] [Google Scholar]
  17. Van Nieuwenhove S. Advances in sleeping sickness therapy. Ann Soc Belg Med Trop. 1992;72 (Suppl 1):39–51. [PubMed] [Google Scholar]
  18. Yarlett N., Bacchi C. J. Effect of DL-alpha-difluoromethylornithine on methionine cycle intermediates in Trypanosoma brucei brucei. Mol Biochem Parasitol. 1988 Jan 1;27(1):1–10. doi: 10.1016/0166-6851(88)90019-9. [DOI] [PubMed] [Google Scholar]
  19. Yarlett N., Garofalo J., Goldberg B., Ciminelli M. A., Ruggiero V., Sufrin J. R., Bacchi C. J. S-adenosylmethionine synthetase in bloodstream Trypanosoma brucei. Biochim Biophys Acta. 1993 Mar 24;1181(1):68–76. doi: 10.1016/0925-4439(93)90092-f. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES